| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 17/11/16 | 07:00:14 | 17 Nov 2016 | Notice of Interim Results | RNS | |
| 01/11/16 | 12:30:03 | 1 Nov 2016 | Grant of Options | RNS | |
| 15/09/16 | 08:00:09 | 15 Sept 2016 | Update re SFX-01 Data at ECTRIMS 2016 | RNS | |
| 08/09/16 | 16:30:26 | 8 Sept 2016 | Presentation of SFX-01 Data at ECTRIMS 2016 | RNS | |
| 24/08/16 | 16:15:43 | 24 Aug 2016 | Orphan Designation in the USA in SAH | RNS | |
| 17/08/16 | 08:00:07 | 17 Aug 2016 | Approval for Phase II Study in Breast Cancer | RNS | |
| 24/06/16 | 16:36:43 | 24 Jun 2016 | Result of AGM | RNS | |
| 09/06/16 | 08:00:06 | 9 Jun 2016 | Grant of Options | RNS | |
| 02/06/16 | 08:00:07 | 2 Jun 2016 | Posting of Annual Report and AGM Notice | RNS | |
| 31/05/16 | 08:00:16 | 31 May 2016 | Final Results | RNS | |
| 09/05/16 | 08:00:08 | 9 May 2016 | Notification of Preliminary Results | RNS | |
| 03/05/16 | 08:00:21 | 3 May 2016 | First Patient Dosed in Phase II Trial | RNS | |
| 02/03/16 | 07:00:10 | 2 Mar 2016 | Approval of Phase II Clinical Trial in SAH | RNS | |
| 19/01/16 | 15:23:11 | 19 Jan 2016 | Correction: Director Share Purchases | RNS | |
| 19/01/16 | 07:00:06 | 19 Jan 2016 | Director Share Purchases | RNS | |
| 11/01/16 | 07:00:05 | 11 Jan 2016 | Exercise of Options | RNS | |
| 04/01/16 | 07:00:12 | 4 Jan 2016 | Appoints Chief Medical Officer | RNS | |
| 07/12/15 | 07:00:08 | 7 Dec 2015 | Half Yearly Report | RNS | |
| 23/11/15 | 07:00:05 | 23 Nov 2015 | Expands Pipeline with Novel Compounds | RNS | |
| 16/11/15 | 07:00:09 | 16 Nov 2015 | Notification of Half Year Results | RNS | |
| 23/10/15 | 12:45:02 | 23 Oct 2015 | Notification of Major Interest in Shares | RNS | |
| 21/10/15 | 08:00:06 | 21 Oct 2015 | First Day of Dealings | RNS |
| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 17/11/16 | 07:00:14 | 17 Nov 2016 | Notice of Interim Results | RNS | |
| 01/11/16 | 12:30:03 | 1 Nov 2016 | Grant of Options | RNS | |
| 15/09/16 | 08:00:09 | 15 Sept 2016 | Update re SFX-01 Data at ECTRIMS 2016 | RNS | |
| 08/09/16 | 16:30:26 | 8 Sept 2016 | Presentation of SFX-01 Data at ECTRIMS 2016 | RNS | |
| 24/08/16 | 16:15:43 | 24 Aug 2016 | Orphan Designation in the USA in SAH | RNS | |
| 17/08/16 | 08:00:07 | 17 Aug 2016 | Approval for Phase II Study in Breast Cancer | RNS | |
| 24/06/16 | 16:36:43 | 24 Jun 2016 | Result of AGM | RNS | |
| 09/06/16 | 08:00:06 | 9 Jun 2016 | Grant of Options | RNS | |
| 02/06/16 | 08:00:07 | 2 Jun 2016 | Posting of Annual Report and AGM Notice | RNS | |
| 31/05/16 | 08:00:16 | 31 May 2016 | Final Results | RNS | |
| 09/05/16 | 08:00:08 | 9 May 2016 | Notification of Preliminary Results | RNS | |
| 03/05/16 | 08:00:21 | 3 May 2016 | First Patient Dosed in Phase II Trial | RNS | |
| 02/03/16 | 07:00:10 | 2 Mar 2016 | Approval of Phase II Clinical Trial in SAH | RNS | |
| 19/01/16 | 15:23:11 | 19 Jan 2016 | Correction: Director Share Purchases | RNS | |
| 19/01/16 | 07:00:06 | 19 Jan 2016 | Director Share Purchases | RNS | |
| 11/01/16 | 07:00:05 | 11 Jan 2016 | Exercise of Options | RNS | |
| 04/01/16 | 07:00:12 | 4 Jan 2016 | Appoints Chief Medical Officer | RNS | |
| 07/12/15 | 07:00:08 | 7 Dec 2015 | Half Yearly Report | RNS | |
| 23/11/15 | 07:00:05 | 23 Nov 2015 | Expands Pipeline with Novel Compounds | RNS | |
| 16/11/15 | 07:00:09 | 16 Nov 2015 | Notification of Half Year Results | RNS | |
| 23/10/15 | 12:45:02 | 23 Oct 2015 | Notification of Major Interest in Shares | RNS | |
| 21/10/15 | 08:00:06 | 21 Oct 2015 | First Day of Dealings | RNS |